Birmingham, 4 Active Studies

Heart Disease Clinical Trials in Birmingham,

Find 4 actively recruiting heart disease clinical trials in Birmingham, . Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
33,100
Enrolling

Recruiting Heart Disease Studies in Birmingham

RecruitingBirmingham, NCT06292013

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart ...

16,700 participants
Eli Lilly and Company
View Study Details
RecruitingBirmingham, NCT07000357

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

The purpose of this phase 3, randomized, placebo controlled, event-driven study is to assess the effect of AZD0780, an oral PCSK9 inhibitor, compared with placebo in reducing the risk of MACE-PLUS in ...

15,100 participants
AstraZeneca
View Study Details
RecruitingBirmingham, NCT05618353

The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

Heart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with heart disease undergoing major surgery are...

700 participants
VA Office of Research and Development
View Study Details
RecruitingBirmingham, NCT06875973

Pelacarsen Roll-over Extension Program

This non-randomized, rollover extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed either of the double-blind parent studies (CTQJ230A1...

600 participants
Novartis Pharmaceuticals
View Study Details

About Heart Disease Clinical Trials in Birmingham

Heart disease is the leading cause of death worldwide, encompassing conditions that affect the heart and blood vessels. Coronary artery disease, the most common type, occurs when arteries supplying the heart become narrowed or blocked. Risk factors include high blood pressure, high cholesterol, diabetes, and smoking.

There are currently 4 heart disease clinical trials recruiting participants in Birmingham, . These studies are seeking a combined 33,100 participants. Research is being sponsored by Eli Lilly and Company, AstraZeneca, VA Office of Research and Development and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Disease Clinical Trials in Birmingham — FAQ

Are there heart disease clinical trials in Birmingham?

Yes, there are 4 heart disease clinical trials currently recruiting in Birmingham, . Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What heart disease treatments are being tested?

The 4 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for heart disease.

Data updated March 2, 2026 from ClinicalTrials.gov